It was not a particularly great time for Hepion Pharmaceuticals (NASDAQ:HEPA) shareholders yesterday as the company’s stock nosedived sharply and declined by as much as 13%. However, in this regard, it is important to note that the stock fell despite the fact that Hepion announced yesterday that its product CRV 431 managed to hit all …
Continue reading “Hepion Pharmaceuticals (NASDAQ:HEPA) Stock Continues to Trend Lower: Here is Why”